Blood Cancer: Leukaemia, Lymphoma & Myeloma — Care in Hyderabad

Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system. The three main types are leukaemia (white blood cells), lymphoma (the lymphatic system) and myeloma (plasma cells). Unlike solid tumours, there is usually no lump to remove — blood cancer is treated with medicines, and sometimes a transplant, rather than surgery.

The three main types are leukaemia, lymphoma and myeloma. Leukaemia starts in the blood-forming cells of the bone marrow. Lymphoma starts in the lymphocytes of the lymph nodes and lymphatic system, and is divided into Hodgkin and non-Hodgkin lymphoma. Myeloma starts in plasma cells in the bone marrow. There is also a smaller group of related bone-marrow disorders (such as myelodysplastic syndromes and myeloproliferative neoplasms). Each main type has several subtypes that behave and are treated differently.

All three are cancers of white blood cells, but they begin in different places. Leukaemia starts in the bone marrow and spills cancerous cells into the bloodstream, so symptoms are mostly blood-related (tiredness, infections, bruising). Lymphoma starts in lymphocytes within the lymph nodes and lymphatic tissue, and usually shows up as a swollen lymph node. Myeloma starts in plasma cells in the bone marrow and often causes bone pain, fractures, kidney problems and low blood counts. Despite the differences, all three are diagnosed with blood tests, bone marrow or lymph node examination and imaging, and many of the same haemato-oncology specialists treat all three.

The most common early signs are persistent tiredness or weakness (from anaemia), frequent or hard-to-shake infections and unexplained fever (from abnormal white cells), and easy bruising or bleeding (from low platelets). Others include a painless swollen lymph node, bone or joint pain, drenching night sweats, and unexplained weight loss. The unifying theme is that symptoms persist or worsen over weeks rather than settling on their own — and many overlap with everyday illness, so persistent or unexplained ones deserve a check, often starting with a simple blood test.

Probably not — the common symptoms of blood cancer (tiredness, infections, bruising, swollen glands) far more often come from ordinary causes like a viral illness or low iron. But symptoms that are persistent or unexplained, especially with an abnormal blood test, should be checked. A simple blood count is often the first step and can reassure you or point to what is going on.

Usually not — most swollen lymph nodes are caused by infections and settle within a few weeks. A node is more worth checking if it is painless, firm, keeps growing, lasts more than a few weeks, or comes with night sweats, fever or weight loss. If in doubt, get it looked at — a persistent node can be assessed with a simple examination and, if needed, a biopsy.

Often, yes — many blood cancers are among the most treatable and curable cancers. Hodgkin lymphoma and childhood leukaemia have very high cure rates, and targeted therapy has transformed some others, such as chronic myeloid leukaemia (now controlled with a daily tablet). Even blood cancers that are not usually considered curable, like myeloma or chronic leukaemias, can often be controlled for many years. Your outlook depends on the exact type and subtype.

Acute blood cancers grow quickly and need prompt treatment; chronic ones grow slowly and may be carefully monitored (“watchful waiting”) before any treatment is needed. Which one you have shapes how urgently, and how, it is treated — but both are managed by a specialist team, and slow-growing types can often be controlled for many years.

Diagnosis usually starts with a complete blood count that flags an abnormality, followed by a bone marrow or lymph node biopsy to confirm, and specialised lab tests — flow cytometry and genetic or molecular testing — that identify the exact type and subtype. For lymphoma, a PET-CT scan checks how widespread it is. This precise subtyping is what makes modern, personalised treatment possible.

A simple complete blood count often gives the first clue — it can show anaemia, abnormal or very high or low white cells, or low platelets. But a blood count alone cannot confirm the diagnosis or the exact type. A specialist confirms it with a blood film, a bone marrow or lymph node biopsy, and flow cytometry and genetic testing. So a blood test is a very useful starting point, not the final answer.

No. Many blood cancers are treated with medicines alone — chemotherapy, targeted therapy or immunotherapy. A stem cell (bone marrow) transplant, using your own cells or a donor’s, is used for certain blood cancers and can be curative, but it is not needed for everyone. At CION, we provide the medicine-based treatment and coordinate transplant with specialist transplant centres when it is the right option.

Blood cancer is treated systemically — with medicines that reach cancer cells throughout the body — not with surgery. Treatment can include chemotherapy, targeted therapy aimed at the cancer’s specific genetic change, immunotherapy, and radiation for some lymphomas. For many blood cancers a stem cell transplant can be curative, and CAR T-cell therapy is an option for some — both coordinated with specialist centres. Some slow-growing types are carefully monitored rather than treated straight away.

CAR T-cell therapy is a modern form of cellular immunotherapy in which some of your own immune (T) cells are collected, re-engineered in a lab to recognise and attack the cancer, and returned to you. It has produced remarkable results in certain lymphomas and leukaemias, particularly when other treatments have not worked. It is delivered at specialist centres; CION coordinates access to CAR-T with those partner centres as part of your overall care.

Yes — leukaemia is in fact the commonest cancer in children. The good news is that childhood leukaemia, particularly acute lymphoblastic leukaemia (ALL), has one of the highest cure rates of any cancer, with most children cured. Children’s blood cancers are treated by paediatric and haemato-oncology teams; see our page on paediatric cancer care for more.

Blood cancers begin when a blood cell’s DNA changes, and for most people there is no clear cause. Some things raise the risk: older age, a family history, previous radiation or chemotherapy for another cancer, certain chemical exposures such as benzene, and some infections or a weakened immune system. But blood cancer can affect any age, including children, and having a risk factor does not mean you will get cancer.

Most blood cancer is not inherited. A family history slightly raises the risk for a few types, and some rare inherited syndromes increase risk, but the great majority of blood cancers happen in people with no family history at all. Having a relative with a blood cancer does not mean you will develop one — if you are concerned, a specialist can advise whether any assessment is worthwhile.

For some slow-growing blood cancers — such as certain chronic leukaemias and low-grade lymphomas — the wisest first step can be careful monitoring rather than immediate treatment. This is called watch and wait, or watchful waiting. You are reviewed regularly, and treatment begins only if and when it is needed. It is a recognised, evidence-based approach that avoids unnecessary treatment while keeping you closely observed.

Cost depends on the type, subtype and treatment — chemotherapy, targeted therapy, immunotherapy, radiation, or a stem cell transplant — so it is best given as an indicative range after assessment. A stem cell transplant is delivered via a specialist partner centre and may be billed there. Eligible treatment may be covered under Aarogyasri or PMJAY at empanelled centres. Use the cost estimator on this page for an indicative figure, then request a callback for an accurate estimate.

Eligible blood cancer treatment may be largely covered under Aarogyasri and PMJAY at empanelled centres, including many diagnostic tests, chemotherapy and supportive care. Because blood cancer treatment is often long, sustained financial support matters — our team helps check your eligibility and guides you on private insurance and EMI so cost does not delay care. Where a treatment such as a transplant is delivered at a partner centre, we explain clearly what is covered and where.